Field experience trials comparing narasin and monensin.
Narasin is effective against all species of chicken coccidia when tested in battery cage and floor pen studies. To confirm the efficacy of narasin under practical broiler production conditions, the drug was fed at concentrations of 60 ppm or 80 ppm to broiler chickens being raised by six different commercial broiler producers in five different geographic areas. Monensin was fed in each trial at a concentration of 100 ppm or 121 ppm as a reference control. The usual management practices of each of the integrated broiler companies were followed throughout the respective trials. Nine trials were conducted and approximately 100,000 broilers were tested for each treatment. No adverse reactions attributable to treatments were observed in any of the trials, and performance results obtained with narasin-medicated birds were generally comparable with those obtained with monensin-medicated birds in the same trial. These findings support the conclusion that narasin at final feed concentrations in the range of 60 to 80 ppm can be safely and effectively used as an anticoccidial agent in commercial broiler production facilities.
Jeffers
T K
TK
Lilly Research Laboratories, Division of Eli Lilly and Company, Greenfield, Indiana 46140.
Tonkinson
L V
LV
Camp
L J
LJ
Murphy
C N
CN
Schlegel
B F
BF
Snyder
D L
DL
Young
D C
DC
D000818:Animals; D002645:Chickens / Q000469:parasitology*; D003048:Coccidiosis / Q000188:drug therapy / Q000662:veterinary*; D003049:Coccidiostats / Q000627:therapeutic use*; D008985:Monensin / Q000627:therapeutic use*; D011201:Poultry Diseases / Q000188:drug therapy* / Q000469:parasitology; D011714:Pyrans / Q000627:therapeutic use*
D003049:Coccidiostats; D011714:Pyrans; D008985:Monensin; C013612:narasin